Millicom (Tigo) share repurchase activity
May 17, 2024 17:30 ET
|
Millicom International Cellular S.A.
Millicom (Tigo) share repurchase activity Luxembourg, May 17, 2024 – Pursuant to the share repurchase program announced on December 15, 2023, Millicom repurchased 36,701 of its Swedish Depository...
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
May 17, 2024 17:15 ET
|
Iovance Biotherapeutics, Inc.
SAN CARLOS, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and...
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
May 17, 2024 17:00 ET
|
Achilles Therapeutics PLC
LONDON, May 17, 2024 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies targeting clonal...
Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action
May 17, 2024 17:00 ET
|
Athira Pharma, Inc.
BOTHELL, Wash., May 17, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health...
Plus Therapeutics Announces New Employment Inducement Grants
May 17, 2024 17:00 ET
|
Plus Therapeutics Inc.
Plus Therapeutics Announces New Employment Inducement Grants
BriaCell Therapeutics Announces Closing of $5.0 Million Registered Direct Offering
May 17, 2024 16:33 ET
|
BriaCell Therapeutics Corp.
PHILADELPHIA and VANCOUVER, British Columbia, May 17, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage...
DBV Technologies Announces Plan to Implement ADS Ratio Change
May 17, 2024 16:30 ET
|
DBV Technologies S.A.
Châtillon, France, May 17, 2024 DBV Technologies Announces Plan to Implement ADS Ratio Change DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT—CUSIP: 23306J101), a...
Oculis updates share capital for its existing at-the-market offering program
May 17, 2024 16:30 ET
|
Oculis Holding AG
ZUG, May 17, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company, has issued registered ordinary shares of the...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
May 17, 2024 16:30 ET
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
Primech Holdings Limited Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
May 17, 2024 16:30 ET
|
Primech Holdings Ltd.
SINGAPORE, May 17, 2024 (GLOBE NEWSWIRE) -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and...